Categories AlphaGraphs, Earnings, Health Care

Infographic: Highlights from Biogen’s (BIIB) Q3 2022 earnings results

Pharma giant Biogen Inc. (NASDAQ: BIIB) on Tuesday announced financial results for the third quarter of 2022, reporting a double-digit drop in revenues and adjusted earnings that is unchanged from the year-ago period.

Biogen Q3 2022 earnings infographic

Third-quarter profit, adjusted for one-off items, remained unchanged at $4.77 per share. Meanwhile, net profit more than doubled year-over-year to $1.13 billion or $7.84 per share.

Revenues decreased 10% annually to $2.51 billion during the three-month period, mainly reflecting an 11% fall in sales at the core product segment.

“We are excited about the topline results of the Clarity AD trial for lecanemab and believe this potential new therapy could provide a meaningful benefit for Alzheimer’s patients. We also continue to make progress toward delivering new impactful therapies for patients suffering from depression and SOD1 ALS, with important upcoming regulatory milestones,” said Biogen’s CEO Michel Vounatsos.

Prior Performance

  • Biogen Q2 2022 Earnings Infographic
  • Biogen Q3 2021 earnings

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

CrowdStrike: Why this cybersecurity stock is a good investment for 2023

CrowdStrike Holdings, Inc. (NASDAQ: CRWD) has steadily expanded its subscriber base over the years, riding the ever-growing demand for cybersecurity solutions. As digital adoption continues -- which accelerated after the

CRM Results: Salesforce Q3 earnings beat; revenues rise 14%

Customer relationship management platform Salesforce, Inc. (NYSE: CRM) on Wednesday reported an increase in third-quarter adjusted earnings, aided by double-digit growth in revenues. The numbers surpassed analysts' predictions. Third-quarter profit,

Hormel Foods (HRL) provides downbeat outlook as it expects volatile and high-cost environment in FY2023

Shares of Hormel Foods Corporation (NYSE: HRL) were down over 4% on Wednesday after the company delivered mixed results for the fourth quarter of 2022 and provided a bleak outlook

Add Comment
Viewing Highlight